Literature DB >> 18690106

Characterization of behavioral response to amphetamine, tyrosine hydroxylase levels, and dopamine receptor levels in neurokinin 3 receptor knockout mice.

Rebecca E Nordquist1, Helene Savignac, Meike Pauly-Evers, Gaby Walker, Fred Knoflach, Edilio Borroni, Patricia Glaentzlin, Bernd Bohrmann, Jurg Messer, Laurence Ozmen, Anita Albientz, Will Spooren.   

Abstract

The neurokinin 3 (NK3) receptor is a novel target under investigation for improvement of symptoms of schizophrenia, because of its ability to modulate dopaminergic signaling. To further understanding of the function of this receptor, sensitivity to dopaminergic stimuli and levels of dopaminergic receptors and tyrosine hydroxylase in NK3 receptor knockout mice were studied. Knockout of the receptor was confirmed by lack of NK3 protein and lack of electrophysiological responsivity of presumed dopaminergic neurons to senktide. NK3 receptor knockout mice showed mild hyperlocomotion and deficits on the rotarod. NK3 receptor knockout mice did not show significant differences in sensitivity to locomotor effects of acute amphetamine (0.3, 1, and 3 mg/kg subcutaneously) or significant alterations in sensitization to locomotor effects of amphetamine, but did show nonsignificant hyperreactivity to 1 mg/kg amphetamine and a nonsignificantly increased propensity to develop sensitization. A small decrease in D1 receptor binding was seen in the dorsal striatum and olfactory tubercle, and a small decrease of in tyrosine hydroxylase in the olfactory tubercle, but no change was seen in D2 receptor binding. Together, these results support a role for the NK3 receptor in reactivity to dopaminergic stimuli, but the lack of robust changes indicates that the sensitivity to dopamine may be activity-dependent or benign in nature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690106     DOI: 10.1097/FBP.0b013e32830cd7f5

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  6 in total

1.  Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell.

Authors:  Nan Gao; John Le Lay; Wei Qin; Nicolai Doliba; Jonathan Schug; Alan J Fox; Olga Smirnova; Franz M Matschinsky; Klaus H Kaestner
Journal:  Mol Endocrinol       Date:  2010-06-09

Review 2.  Neurokinin B and the hypothalamic regulation of reproduction.

Authors:  Naomi E Rance; Sally J Krajewski; Melinda A Smith; Marina Cholanian; Penny A Dacks
Journal:  Brain Res       Date:  2010-08-25       Impact factor: 3.252

3.  Uncovering novel reproductive defects in neurokinin B receptor null mice: closing the gap between mice and men.

Authors:  Jasmine J Yang; Claudia S Caligioni; Yee-Ming Chan; Stephanie B Seminara
Journal:  Endocrinology       Date:  2012-01-17       Impact factor: 4.736

4.  The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics.

Authors:  F Josef van der Staay; Bruno Pouzet; Michel Mahieu; Rebecca E Nordquist; Teun Schuurman
Journal:  Psychopharmacology (Berl)       Date:  2009-07-23       Impact factor: 4.530

5.  Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity.

Authors:  Chinwe A Nwaneshiudu; Ellen M Unterwald
Journal:  Neuropharmacology       Date:  2009-06-03       Impact factor: 5.250

6.  Genetic marking and characterization of Tac2-expressing neurons in the central and peripheral nervous system.

Authors:  Lynn Mar; Fu-Chia Yang; Qiufu Ma
Journal:  Mol Brain       Date:  2012-01-24       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.